Ninomiya Takahiro

Hanyuda Akiko, Raita Yoshihiko, Ninomiya Takahiro, Hashimoto Kazuki, Takada Naoko, Sato Kota et al.

This study identified five distinct open-angle glaucoma endotypes using metabolomics. One high-risk endotype showed faster central vision loss, linked to dyslipidemia and oxidative stress, suggesting personalized treatment targets.

Ninomiya Takahiro, Kiyota Naoki, Sharma Parmanand, Omodaka Kazuko, Himori Noriko, Yasuda Masayuki et al.

AI-assisted OCTA-measured FAZ changes correlated with inferocentral visual field defect progression in glaucoma. This suggests FAZ parameters could be valuable markers for monitoring disease worsening.

Takahashi Naoki, Omodaka Kazuko, Kikawa Tsutomu, Ninomiya Takahiro, Kiyota Naoki, Tsuda Satoru et al.

This study found that multiple factors, including age, antioxidant potential, corneal hysteresis, and optic nerve blood flow, contribute to visual acuity decline in glaucoma patients with macular ganglion cell loss, suggesting multifactorial assessment is needed.

Ninomiya Takahiro, Kunikata Hiroshi, Ishikawa Makoto, Nakazawa Toru

Takahashi Naoki, Omodaka Kazuko, Nakazawa Arata, Kikawa Tsutomu, Ninomiya Takahiro, Kiyota Naoki et al.

This study found that the enlargement rate of retinal nerve fiber defect angles, measured by en face OCT, strongly correlates with visual field progression, offering a promising new way to monitor glaucoma.